Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

COVID-19 RESEARCH

COVID-19 RESEARCH

ARENSIA has contributed to numerous research projects with innovative compounds enrolling more than 1,500 COVID-19 patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

WEBINAR SUMMARY: CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNITIES

HOME · NEWS · WEBINAR SUMMARY: CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNITIES
  • 130 participants
  • 25 countries
  • 7 expert speakers
  • 5 different time zones

This is a summary of the last week's successful live webinar about the status quo and opportunities of performing clinical trials in Ukraine. During the session, representatives of Ukrainian Health Authorities, Sponsor, an international courier company, a local clinical laboratory, and ARENSIA clinic in Kyiv shared firsthand their experiences over the past 6 months as well as features from current daily operations. With an increasing number of Sponsors resuming the restart of their ongoing trials or initiating new trials in Ukraine, valuable insights from the speakers and panelists helped to answer vivid questions from the audience concerning the safe performance of clinical trials in Ukraine.
Many thanks to everybody who joined! Stay tuned for further webinar announcements.

07.10.2022
VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse